BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 319180)

  • 1. Antitumor antibodies in human breast cancer sera as detected by fixed cell immunofluorescence and living cell membrane immunofluorescence assays.
    Nordquist RE; Schafer FB; Manning NE; Ishmael DR; Hoge AF
    J Lab Clin Med; 1977 Feb; 89(2):257-61. PubMed ID: 319180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kansas breast study: a progress report.
    Estes NC; Morse PA; Jewell WR; Humphrey LJ
    J Kans Med Soc; 1975 Feb; 76(2):37-9. PubMed ID: 1113009
    [No Abstract]   [Full Text] [Related]  

  • 3. Serologic detection of breast cancer.
    Estes NC; Boehm OR; Jewell WR; Humphrey LJ
    Bull Soc Int Chir; 1974 Mar; 33(2):85-90. PubMed ID: 4210924
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
    Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
    Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
    Ceriani RL; Peterson JA; Blank EW
    Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of antibody against intracytoplasmic A-particles of mouse mammary tumor virus in sera from breast cancer patients.
    Ogawa H; Tanaka H
    Gan; 1978 Aug; 69(4):539-44. PubMed ID: 213337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the antibody-dependent cellular cytotoxicity test to detect antibodies in sera of breast cancer patients.
    Plain MJ; Whitehead RH; Jose DG
    J Natl Cancer Inst; 1981 Apr; 66(4):619-24. PubMed ID: 7014964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunofluorescence studies in stomach and breast carcinomas and benign breast diseases].
    Kasper M
    Acta Histochem; 1984; 75(1):37-45. PubMed ID: 6438999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and localization of the secretory component in tumours of the exocrine glands.
    Musiani P; Piantelli M; Pozzuoli R
    Pathol Eur; 1974; 9(1):17-23. PubMed ID: 4371701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody studies of sera from patients with breast cancer.
    Estes NC; Morse PA; Humphrey LJ
    Surg Forum; 1974; 25(0):121-3. PubMed ID: 4612763
    [No Abstract]   [Full Text] [Related]  

  • 15. Humoral immunologic response in patients with tumors of the breast.
    Glazman H; Salwa J; Harlozińska A
    Arch Immunol Ther Exp (Warsz); 1973; 21(1):175-84. PubMed ID: 4720430
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL; Hammer C
    J Med; 1981; 12(6):447-53. PubMed ID: 7033427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody in patients with mammary disease.
    Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma.
    Holder WD; Wells SA
    Cancer Res; 1983 Jan; 43(1):239-44. PubMed ID: 6291754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.